{"id":52573,"date":"2023-01-05T14:02:54","date_gmt":"2023-01-05T13:02:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/crescendo-health-launches-to-improve-and-accelerate-clinical-trials-by-unlocking-patient-health-data\/"},"modified":"2023-01-05T14:02:54","modified_gmt":"2023-01-05T13:02:54","slug":"crescendo-health-launches-to-improve-and-accelerate-clinical-trials-by-unlocking-patient-health-data","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/crescendo-health-launches-to-improve-and-accelerate-clinical-trials-by-unlocking-patient-health-data\/","title":{"rendered":"Crescendo Health Launches to Improve and Accelerate Clinical Trials By Unlocking Patient Health Data"},"content":{"rendered":"
\n

\nCrescendo Health\u2019s real-world data platform creates partnerships between researchers and patients to gain greater longitudinal insights into health outcomes from clinical research.<\/i>\n<\/p>\n

\nCompany also raises initial funding from top investors; model proven to work after successful pilot completion with top-three clinical research organization.<\/i>\n<\/p>\n

SAN FRANCISCO–(BUSINESS WIRE)–Crescendo Health<\/a>, an innovative health data company powering the next generation of clinical research, today announced its official launch with a mission to revolutionize how patients contribute real-world data to clinical studies. The company also announced an initial $3.4 million investment from leading early-stage investors, including Define Ventures as well as the founders and CEOs of many other well-known organizations.\n<\/p>\n

<\/a><\/p>\n

\nFounded by the co-founder of Datavant (merged with Ciox<\/a> in a $7 billion deal), and a top product-management leader from Grand Rounds (merged with Doctor On Demand<\/a> to form Included Health), Crescendo Health is a public benefit corporation that is unlocking access to traditionally siloed health data for both patients and clinical research sponsors. The company works with researchers from many types of healthcare organizations, including biopharma, medical device manufacturers and contract research organizations, to provide the tools and support required to collect and integrate information from patients’ routine clinical care, helping them better understand long-term outcomes of new treatments.\n<\/p>\n

\n\u201cPatients participating in clinical trials generate valuable health data throughout their healthcare journey, so researchers shouldn\u2019t be limited to information gathered in the four walls of a research clinic. However, to date, these external real-world data elements weren\u2019t accessible to trial sponsors at scale, which is why we\u2019re building the machinery and support required to change the paradigm,\u201d said Sam Roosz, co-founder and CEO of Crescendo Health. \u201cWe are working towards a future where research is seamlessly integrated with routine clinical care, making participation easy and accessible for patients from all backgrounds.\u201d\n<\/p>\n

\nLed by a world-class team of former clinical research executives from institutions like Stanford and Medidata and seasoned digital product experts, Crescendo Health brings some of the most innovative digital health technologies that are transforming patient care to clinical trials, helping sponsors advance life-saving therapeutics in more efficient and cost-effective ways. The model works by garnering informed consent to collect health data on behalf of people participating in clinical research from any healthcare organization touching their care. Crescendo Health collects this information through APIs, data partnerships, and other methods, converting that data into a format that\u2019s accessible to patients and useful for researchers.\n<\/p>\n

\nAs a result, clinical research sponsors receive an ongoing, longitudinal view of patient health that informs more comprehensive research. Sponsors can leverage Crescendo Health\u2019s model to support a variety of use cases, including:\n<\/p>\n